{"Title": "Sequencing therapy for advanced renal cancer", "Year": 2020, "Source": "Lancet Oncol.", "Volume": "21", "Issue": 1, "Art.No": null, "PageStart": 9, "PageEnd": 11, "CitedBy": 0, "DOI": "10.1016/S1470-2045(19)30781-8", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85077155264&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Carcinoma, Renal Cell", "Humans", "Kidney Neoplasms", "Phenylurea Compounds", "Quinolines", "Sorafenib"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-85077155264", "SubjectAreas": [["Oncology", "MEDI", "2730"]], "AuthorData": {"7004237921": {"Name": "Bex A.", "AuthorID": "7004237921", "AffiliationID": "60015205", "AffiliationName": "Netherlands Cancer Institute"}}}